High-dose versus low-dose cisplatin in advanced head and neck squamous carcinoma: a randomized study. 1985

A Veronesi, and V Zagonel, and U Tirelli, and E Galligioni, and S Tumolo, and L Barzan, and M Lorenzini, and R Comoretto, and E Grigoletto

From November 1981 to February 1983, 64 patients with advanced head and neck squamous carcinoma were randomly treated with either high-dose (120 mg/m2) or low-dose (60 mg/m2) cisplatin. Of the 62 eligible patients, 59 were evaluable: the response rate observed in patients receiving high-dose and low-dose cisplatin was 16.1% and 17.8%, respectively. Survival was superimposable in the two treatment arms. No evidence of dose dependency of cisplatin activity in advanced head and neck squamous carcinoma was noted in this randomized trial.

UI MeSH Term Description Entries
D007267 Injections Introduction of substances into the body using a needle and syringe. Injectables,Injectable,Injection
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D002294 Carcinoma, Squamous Cell A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed) Carcinoma, Epidermoid,Carcinoma, Planocellular,Carcinoma, Squamous,Squamous Cell Carcinoma,Carcinomas, Epidermoid,Carcinomas, Planocellular,Carcinomas, Squamous,Carcinomas, Squamous Cell,Epidermoid Carcinoma,Epidermoid Carcinomas,Planocellular Carcinoma,Planocellular Carcinomas,Squamous Carcinoma,Squamous Carcinomas,Squamous Cell Carcinomas
D002945 Cisplatin An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. Platinum Diamminodichloride,cis-Diamminedichloroplatinum(II),cis-Dichlorodiammineplatinum(II),Biocisplatinum,Dichlorodiammineplatinum,NSC-119875,Platidiam,Platino,Platinol,cis-Diamminedichloroplatinum,cis-Platinum,Diamminodichloride, Platinum,cis Diamminedichloroplatinum,cis Platinum
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005260 Female Females
D006258 Head and Neck Neoplasms Soft tissue tumors or cancer arising from the mucosal surfaces of the LIP; oral cavity; PHARYNX; LARYNX; and cervical esophagus. Other sites included are the NOSE and PARANASAL SINUSES; SALIVARY GLANDS; THYROID GLAND and PARATHYROID GLANDS; and MELANOMA and non-melanoma skin cancers of the head and neck. (from Holland et al., Cancer Medicine, 4th ed, p1651) Cancer of Head and Neck,Head Cancer,Head Neoplasm,Head and Neck Cancer,Head and Neck Neoplasm,Neck Cancer,Neck Neoplasm,Neck Neoplasms,Neoplasms, Upper Aerodigestive Tract,UADT Neoplasm,Upper Aerodigestive Tract Neoplasm,Upper Aerodigestive Tract Neoplasms,Cancer of Head,Cancer of Neck,Cancer of the Head,Cancer of the Head and Neck,Cancer of the Neck,Head Neoplasms,Head, Neck Neoplasms,Neoplasms, Head,Neoplasms, Head and Neck,Neoplasms, Neck,UADT Neoplasms,Cancer, Head,Cancer, Neck,Cancers, Head,Cancers, Neck,Head Cancers,Neck Cancers,Neoplasm, Head,Neoplasm, Neck,Neoplasm, UADT,Neoplasms, UADT
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

A Veronesi, and V Zagonel, and U Tirelli, and E Galligioni, and S Tumolo, and L Barzan, and M Lorenzini, and R Comoretto, and E Grigoletto
July 2017, Head & neck,
A Veronesi, and V Zagonel, and U Tirelli, and E Galligioni, and S Tumolo, and L Barzan, and M Lorenzini, and R Comoretto, and E Grigoletto
October 2021, Journal of medical imaging and radiation oncology,
A Veronesi, and V Zagonel, and U Tirelli, and E Galligioni, and S Tumolo, and L Barzan, and M Lorenzini, and R Comoretto, and E Grigoletto
January 1987, Cancer chemotherapy and pharmacology,
A Veronesi, and V Zagonel, and U Tirelli, and E Galligioni, and S Tumolo, and L Barzan, and M Lorenzini, and R Comoretto, and E Grigoletto
July 2015, Cancer research and treatment,
A Veronesi, and V Zagonel, and U Tirelli, and E Galligioni, and S Tumolo, and L Barzan, and M Lorenzini, and R Comoretto, and E Grigoletto
March 2012, Medical oncology (Northwood, London, England),
A Veronesi, and V Zagonel, and U Tirelli, and E Galligioni, and S Tumolo, and L Barzan, and M Lorenzini, and R Comoretto, and E Grigoletto
May 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
A Veronesi, and V Zagonel, and U Tirelli, and E Galligioni, and S Tumolo, and L Barzan, and M Lorenzini, and R Comoretto, and E Grigoletto
October 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology,
A Veronesi, and V Zagonel, and U Tirelli, and E Galligioni, and S Tumolo, and L Barzan, and M Lorenzini, and R Comoretto, and E Grigoletto
December 2023, Cancer investigation,
A Veronesi, and V Zagonel, and U Tirelli, and E Galligioni, and S Tumolo, and L Barzan, and M Lorenzini, and R Comoretto, and E Grigoletto
February 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
A Veronesi, and V Zagonel, and U Tirelli, and E Galligioni, and S Tumolo, and L Barzan, and M Lorenzini, and R Comoretto, and E Grigoletto
April 2014, Oral oncology,
Copied contents to your clipboard!